Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dent

Showing results (201-210 of 243) with videos related to

Pageof 25
Sort By:
Blood|July 1, 1987
Proteolytic degradation of von Willebrand factor after DDAVP administration in normal individualsJ Batlle, M F Lopez-Fernandez, A Lopez-Borrasca, et al.
Breast Cancer Research and Treatment|December 1, 1987
Estrogen receptor determination by monoclonal antibody in fine needle aspiration breast cancer cytologies: a marker of hormone responseG V Burton, J L Flowers, E B Cox, et al.
Journal of Synchrotron Radiation|July 21, 2004
High-quality energy-dispersive XAFS on the 1 s timescale applied to electrochemical and catalyst systemsA Dent, J Evans, M Newton, et al.
International Journal of Cancer|March 16, 1995
Receptor tyrosine kinases expressed in metastatic colon cancerR J Craven, L H Xu, T M Weiner, et al.
Immunology and Cell Biology|August 17, 2011
Protection against Nippostrongylus brasiliensis infection in mice is independent of GM-CSFDoris S C Shim, Heidi C Schilter, Michelle L Knott, et al.
Memorias Do Instituto Oswaldo Cruz|January 1, 1997
Immune responses of IL-5 transgenic mice to parasites and aeroallergensL A Dent, C Daly, A Geddes, et al.
Parasite Immunology|May 30, 2008
Toxocara canis larval excretory/secretory proteins impair eosinophil-dependent resistance of mice to Nippostrongylus brasiliensisP R Giacomin, M Cava, D J Tumes, et al.
Breast Cancer Research : BCR|September 26, 2013
Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancerRebecca A Dent, Geoffrey J Lindeman, Mark Clemons, et al.
Parasite Immunology|July 1, 1997
Eosinophilic interleukin 5 (IL-5) transgenic mice: eosinophil activity and impaired clearance of Schistosoma mansoniL A Dent, G H Munro, K P Piper, et al.
JCO Precision Oncology|November 4, 2022
Exquisitely Platinum-Sensitive Triple-Negative Breast Cancer, Time for <i>BRCA</i> Methylation Testing?Tira J Tan, J Lynn Fink, Timothy K Tay, et al.
Pageof 25

Showing results (201-210 of 243) with videos related to

Sort By:
Pageof 25
Blood|July 1, 1987
Proteolytic degradation of von Willebrand factor after DDAVP administration in normal individualsJ Batlle, M F Lopez-Fernandez, A Lopez-Borrasca, et al.
Breast Cancer Research and Treatment|December 1, 1987
Estrogen receptor determination by monoclonal antibody in fine needle aspiration breast cancer cytologies: a marker of hormone responseG V Burton, J L Flowers, E B Cox, et al.
Journal of Synchrotron Radiation|July 21, 2004
High-quality energy-dispersive XAFS on the 1 s timescale applied to electrochemical and catalyst systemsA Dent, J Evans, M Newton, et al.
International Journal of Cancer|March 16, 1995
Receptor tyrosine kinases expressed in metastatic colon cancerR J Craven, L H Xu, T M Weiner, et al.
Immunology and Cell Biology|August 17, 2011
Protection against Nippostrongylus brasiliensis infection in mice is independent of GM-CSFDoris S C Shim, Heidi C Schilter, Michelle L Knott, et al.
Memorias Do Instituto Oswaldo Cruz|January 1, 1997
Immune responses of IL-5 transgenic mice to parasites and aeroallergensL A Dent, C Daly, A Geddes, et al.
Parasite Immunology|May 30, 2008
Toxocara canis larval excretory/secretory proteins impair eosinophil-dependent resistance of mice to Nippostrongylus brasiliensisP R Giacomin, M Cava, D J Tumes, et al.
Breast Cancer Research : BCR|September 26, 2013
Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancerRebecca A Dent, Geoffrey J Lindeman, Mark Clemons, et al.
Parasite Immunology|July 1, 1997
Eosinophilic interleukin 5 (IL-5) transgenic mice: eosinophil activity and impaired clearance of Schistosoma mansoniL A Dent, G H Munro, K P Piper, et al.
JCO Precision Oncology|November 4, 2022
Exquisitely Platinum-Sensitive Triple-Negative Breast Cancer, Time for <i>BRCA</i> Methylation Testing?Tira J Tan, J Lynn Fink, Timothy K Tay, et al.
Pageof 25